The company's performance was bolstered by a 71% year-on-year rise in adjusted EBITDA, which pushed margins up by 123 basis points to reach 16%. Significant enterprise interest in artificial intelligence models catalyzed growth, led by an extraordinary 79% expansion in the healthcare and life sciences division. Additionally, the business supports its technical capabilities by deploying more than 6,000 global staff and reinvesting over 6% of revenue into research and development. Despite this momentum, the shares remain approximately 27% below the peak level recorded in May 2026.
Key points
Expanding enterprise artificial intelligence adoption is helping accelerate the company's…: Expanding enterprise artificial intelligence adoption is helping accelerate the company's revenue growth across key industries.
Profitability improved substantially as adjusted EBITDA margins expanded by 123 basis poi…: Profitability improved substantially as adjusted EBITDA margins expanded by 123 basis points to 16%.
Substantial investments continue into proprietary platforms, with over 6% of revenue funn…: Substantial investments continue into proprietary platforms, with over 6% of revenue funneled into artificial intelligence development.
Sources checked by our analysis pipeline: 1
Shares of Fractal Analytics rallied as much as 12% on Wednesday, November 4, after the artificial intelligence (AI) company reported strong earnings for the September quarter of FY27. The stock climbed to an intraday high of ₹820.75 on the BSE, compared with its previous closing price of ₹732.60.
The strong rally followed a sharp improvement in profitability, double-digit revenue growth and an expansion in operating margins. The company also reported its first-ever quarter with operating revenue crossing the $100 million mark, reflecting continued demand for its enterprise AI solutions.
Fractal Analytics reported a 139% year-on-year (YoY) jump in net income to ₹79.2 crore in Q2FY27. Consolidated operating revenue increased 20% YoY to ₹956.5 crore, marking the company's first quarter with revenue exceeding $100 million.
Adjusted EBITDA grew 71% YoY, while the adjusted EBITDA margin expanded by 123 basis points to 16%.
For the quarter ended September 30, 2026, revenue increased 10% in constant currency terms. Growth was led by the healthcare and life sciences (HLS) business, which recorded a 79% YoY increase. The banking, financial services and insurance (BFSI) segment…
Market participants triggered a sharp sell-off in the commodity exchange's stock as profit-taking eclipsed an otherwise robust earnings report. The pullback highlights growing investor sensitivity to stretched valuations, with the firm trading at double the sector average multiple despite doubling its quarterly net profit. Rising operating expenditures and technical resistance levels also contributed to the sudden intraday reversal.
Investor sentiment shifted sharply across regional exchanges as the outcome of the American vote triggered broad selling pressure. Technology companies absorbed the brunt of the downturn, dragging major regional indices lower. The broad retreat reflects immediate financial market sensitivity to shifting political dynamics in the United States.
Elevated borrowing costs fueled by geopolitical conflict in the Middle East and stubborn domestic inflation continue to constrain affordability for prospective buyers. Property values are projected to contract further through 2027 as millions of homeowners face impending refinancing shocks. A sustainable turnaround is expected only when improved deposit conditions and targeted government support restore first-time purchaser activity.